TrialInternational urology and nephrology2017

Treatment of complicated urinary tract infection and acute pyelonephritis by short-course intravenous levofloxacin (750 mg/day) or conventional intravenous/oral levofloxacin (500 mg/day): prospective, open-label, randomized, controlled, multicenter, non-inferiority clinical trial.

Hong Ren et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.